FDA Inspection 999455 — Richard Samuel Finn, M.D. (UCLA School Of Medicine)
The FDA completed an inspection of Richard Samuel Finn, M.D. (UCLA School Of Medicine) on Feb 7, 2017 in Los Angeles, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 7, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Los Angeles, CA (United States)
Additional Details
Clinical Investigator (CI)